Model
Edge
EyePoint Pharmaceuticals Inc.
0002013623
Filing Type
4
Filing Date
3/3/2024
Updated
3/4/24, 10:40 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership